Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD.
作者信息
Kang Wonseok, Kim Seung Up
机构信息
Department of Internal Medicine, Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2013 Sep;19(3):255-7. doi: 10.3350/cmh.2013.19.3.255. Epub 2013 Sep 30.
Abstract
摘要
相似文献
1
Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD.
Clin Mol Hepatol. 2013 Sep;19(3):255-7. doi: 10.3350/cmh.2013.19.3.255. Epub 2013 Sep 30.
2
Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.
Clin Mol Hepatol. 2013 Sep;19(3):258-65. doi: 10.3350/cmh.2013.19.3.258. Epub 2013 Sep 30.
3
The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease.
Med Sci Monit. 2012 Dec;18(12):CR735-40. doi: 10.12659/msm.883601.
4
Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?
World J Gastroenterol. 2013 Nov 14;19(42):7412-8. doi: 10.3748/wjg.v19.i42.7412.
5
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.
Metabolism. 2019 Dec;101:154005. doi: 10.1016/j.metabol.2019.154005. Epub 2019 Nov 9.
6
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
7
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
Hormones (Athens). 2014 Oct-Dec;13(4):519-31. doi: 10.14310/horm.2002.1493. Epub 2014 Nov 5.
8
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
BMC Gastroenterol. 2006 Feb 14;6:6. doi: 10.1186/1471-230X-6-6.
9
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.
Gut. 2006 Nov;55(11):1650-60. doi: 10.1136/gut.2006.091454.
10
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol. 2011 Oct;26(10):1536-43. doi: 10.1111/j.1440-1746.2011.06774.x.
引用本文的文献
1
Prognostic significance of red blood cell distribution width in gastrointestinal disorders.
World J Gastroenterol. 2017 Jul 21;23(27):4879-4891. doi: 10.3748/wjg.v23.i27.4879.
2
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Dig Dis Sci. 2017 Aug;62(8):2150-2158. doi: 10.1007/s10620-017-4592-0. Epub 2017 May 18.
本文引用的文献
1
Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.
Biomark Res. 2013 Feb 4;1(1):7. doi: 10.1186/2050-7771-1-7.
2
Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.
Clin Mol Hepatol. 2013 Sep;19(3):258-65. doi: 10.3350/cmh.2013.19.3.258. Epub 2013 Sep 30.
3
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Liver Int. 2012 Jul;32(6):902-10. doi: 10.1111/j.1478-3231.2012.02781.x. Epub 2012 Mar 21.
4
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
5
Non-invasive assessment of liver fibrosis: the gap between ideal and real.
J Gastroenterol Hepatol. 2011 Jun;26(6):937-9. doi: 10.1111/j.1440-1746.2011.06741.x.
6
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.
7
Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
J Gastroenterol Hepatol. 2010 Sep;25(9):1472-3. doi: 10.1111/j.1440-1746.2010.06432.x.
8
Red cell distribution width: a powerful prognostic marker in heart failure.
Eur J Heart Fail. 2010 Apr;12(4):415. doi: 10.1093/eurjhf/hfq018. Epub 2010 Feb 17.
9
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
Hepatology. 2010 Feb;51(2):454-62. doi: 10.1002/hep.23312.
10
Red blood cell distribution width and mortality risk in a community-based prospective cohort.
Arch Intern Med. 2009 Mar 23;169(6):588-94. doi: 10.1001/archinternmed.2009.55.
Zotero 插件